These mutations (mostly involving cytosolic IDH1, lesser so mitochondrial IDH2) have important consequences for the epigenome and cause extensive DNA methylation in IDH-mutant diffuse gliomas (‘glioma-CpG island methylator phenotype’/G-CIMP) [22, 104]. The gene discussed is IDH2; the disease is central nervous system cancer.